Daiichi Sankyo Co Ltd., Eli Lilly and Company (JOBS) Win European Approval for Prasugrel

BOSTON, Feb 23 (Reuters) - Eli Lilly & Co and Japan's Daiichi Sankyo Co said on Monday that they had won European approval for their blood-thinning drug Efient, also known as prasugrel.
MORE ON THIS TOPIC